Annual IFPMA Reception on the occasion of the 63rd World Health Assembly
19 May 2010
18:30 to 21:00
This event has now passed. To browse our upcoming events click here.
IFPMA Director General Eduardo Pisani welcomed guests, emphasizing that “the IFPMA intends to serve the international health community as a partner, as a resource and as a thought leader”.
The theme was “The Challenges of Improving Women’s Health”. The Indonesian Minister of Health and the WHO Assistant Director General accepted our invitation to speak but were unable to attend at the last minute, and were replaced by Ms. Engko Sosialine, Director for Community and Clinical Pharmacy, Ministry of Health of the Republic of Indonesia and Ms. Tonya Nyagiro, Director, Department of Gender, Women and Health at the WHO. Ms. Joy Marini, Director of Maternal & Child Health, Corporate Contributions Group, Johnson & Johnson, presented her company’s extensive range of programs to improve women’s health in developing countries.
Around 100 persons attended the Reception, including the Rwandan Minister of Health and Ambassador, as well as delegates from the Republic of Congo, Djibouti, Cameroon, Italy, Yemen, Philippines, Mongolia and Venezuela.
Eduardo Pisani has served in the healthcare industry for over 20 years, in different
countries and with roles of increasing responsibility in the field of international public policy
and legal affairs. His most recent position was Vice-President, International Policy and
Government Affairs at Bristol-Myers Squibb, which he joined in 2001.
Previously, Eduardo held positions as legal counsel at Immuno AG in Belgium and Austria,
at Baxter Healthcare in Belgium and Italy, and in European Policy and Government Affairs
at Adamson Associates and SmithKline Beecham in Belgium. He started his career in
1989, in the marketing department of Lederle France.
An Italian national, Eduardo received a degree in Law from the University of Catania, Italy,
in 1987 and was admitted to the Italian Bar in 1991. He studied business administration at
IMMI in Italy and at Vlerick Management School in Belgium, as well as International
Relations at CERIS in Belgium.
Ms Magdalene is Director for Community and Clinical Pharmacy, part of the Directorate
General of Pharmaceutical Care Services and Medical Devices, within the Ministry of
Health of the Republic of Indonesia. She trained as a pharmacist before entering
government service, starting work in the Ambon regional office of the Directorate of Drug
and Food Control. Her next post was in Drug Registration, before being promoted to lead
the department responsible for Monitoring of Adverse Drug Reactions, part of the National
Agency of Drug and Food Control. In 2003, she was made responsible for a significant part
of New Drug Evaluation work within the same Agency. She subsequently became head of
the Sub Directorate of Surveillance and Risk Analysis of Therapeutic Products, before
being elevated to her present position in 2009.
Daisy Mafubelu started her career in public health almost 26 years ago, as a nurse and
midwife. She graduated in Community Health Nursing and Nursing Education from the
University of South Africa and later, in Business Administration from the University of
Stellenbosch. She also holds a postgraduate diploma in health management from the
University of Cape Town.
In 1994 Daisy joined the management ranks of the South African health service, where she
played a significant role in the transformation and management of public health services,
holding several positions in senior management within the public health sector, first as a
Director of Human Resources and later as a Deputy Director-General of Health. She was
named Oliver Tambo Fellow in Public Health Leadership in 1997. This award was made in
recognition of outstanding potential and commitment to provide leadership through public
health service towards improving health and health care for all South Africans.
Before her appointment as Assistant Director-General, Family and Community Health at
the World Health Organization (WHO) on 1st April 2007, Daisy was Health Attaché in the
Permanent Mission of South Africa in Geneva, with the rank of Minister. She was the
coordinator of the African group on health matters and is well known among the Diplomatic
community in Geneva. During the five years she has been in Geneva, she has acquired a
broad knowledge of WHO’s modus operandi, through her active involvement in the
workings of WHO and participation in the intergovernmental processes of the Organization.
Joy Marini is Director, Corporate Contributions, Johnson & Johnson, a position she
assumed in 2007, following 6 years with the Johnson & Johnson Pediatric Institute. Joy is
responsible for Johnson & Johnson’s international programs on maternal and infant health,
gender-based violence, and economic empowerment for women. She has been
instrumental in developing sustainable partnership initiatives, most notably for her efforts
on a Neonatal Resuscitation Program (NRP) in China – a 5-year collaboration between the
Chinese Ministry of Health, the American Academy of Pediatrics (AAP) and Johnson &
Johnson. Joy has contributed to the development of publications for parents and health
professionals, including the Compendium of Postpartum Care with the Association of
Women’s Health, Obstetrics and Neonatal Nursing, and Eating Behaviors of the Young
Child with the AAP.Joy earned her MS Physician Assistant from the University of Medicine
and Dentistry of New Jersey in 1997. She received an MBA from Rider University.